Acadia Pharma -additional information for your consideration.:
*In total Acadia employees nearly 600 people mostly in San Diego California. The company also operates a complete medical research facility in the Netherlands.
*In almost 30 years Acadia has never made a profit.
*In the full 2023-year Acadia reported a net loss of $63.1M or 37c per share but the company hopes to break even in the next 12 months.
*Revenue growth seems to be the only important analyst measure in valuing this stock.
*Acadia share price currently is almost trading at its 52-week low.
*Previous acquisition rumours appear to have disappeared.
*Baker Bros Advisors [hedge fund] own 26.0% of Acadia shares and their investment here represents 14.9% of the entire Baker Bros portfolio.
*Baker Bros have been invested in Acadia since 2010 and obviously bought in very cheaply.
*Julian Baker has been on the Acadia BOD since 2015.
*Acadia CEO Steve Davis is a CPA and lawyer. He is also a director of Bellicum Pharma.
Baker Bros have a 19.9% stake in this company. Over the past year Bellicum lost 91.1% of its share value.
The Baker Bros exit strategy is still the big unknown here.
Kens
Acadia, page-400
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |